Fabiana Tatangelo

Critical role of bevacizumab scheduling in combination with pre-surgical chemo-radiotherapy in MRI-defined high-risk locally advanced rectal cancer: results of the branch trial

Antonella Petrillo, Vincenza Granata, Gerardo Botti, 2015, Oncotarget.

Early diagnosis of malignant melanoma: Proposal of a working formulation for the management of cutaneous pigmented lesions from the Melanoma Cooperative Group.

Riccardo Bono, Alessandro Testori, Antonio Daponte, 2003, International journal of oncology.

Clonal evolution and resistance to EGFR blockade in the blood of colorectal cancer patients

Beatriz Bellosillo, Enzo Medico, Giuseppe Rospo, 2015, Nature Medicine.

Diagnostic accuracy of magnetic resonance, computed tomography and contrast enhanced ultrasound in radiological multimodality assessment of peribiliary liver metastases

Roberta Fusco, Antonella Petrillo, Vincenza Granata, 2017, PloS one.

A randomized phase 3 study on the optimization of the combination of bevacizumab with FOLFOX/OXXEL in the treatment of patients with metastatic colorectal cancer-OBELICS (Optimization of BEvacizumab scheduLIng within Chemotherapy Scheme)

Antonella Petrillo, Vincenza Granata, Gerardo Botti, 2016, BMC Cancer.

18F-FDG PET is an early predictor of pathologic tumor response to preoperative radiochemotherapy in locally advanced rectal cancer.

Cesare Guida, Giuseppe Lucio Cascini, Antonio Avallone, 2006, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.